| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 03/02/2005 | CN1586475A Vitamin C oral disintegration tablet and its preparing method |
| 03/02/2005 | CN1586474A Hydroxymethyl coumarine soft capsule and its preparing method |
| 03/02/2005 | CN1586473A Daphnetic soft capsule and its preparing method |
| 03/02/2005 | CN1586472A Bifendate oral disintegration tablet and its preparing process |
| 03/02/2005 | CN1586471A Silibinin meglumine salt oral disintegration tablet preparation and its preparing method |
| 03/02/2005 | CN1586470A Silibinin oral disintegration tablet and its preparing method |
| 03/02/2005 | CN1586469A Hepedestal oral disintegration tablet and its preparing method |
| 03/02/2005 | CN1586468A Hepadestal soft capsule and its preparing method |
| 03/02/2005 | CN1586466A Compound dispersion tablet of acetaminophen and benadryl and its preparing method |
| 03/02/2005 | CN1586462A New use of glutaraldehyde in preparing aminal medicine |
| 03/02/2005 | CN1191254C Fused pyrrole compounds, pharmaceutical composition containing the same, and the use thereof |
| 03/02/2005 | CN1191240C Nitrogen monoxide synthase inhibitor, its preparation method and application |
| 03/02/2005 | CN1191236C Substituted 6,6-Hetero-dicycloderivative |
| 03/02/2005 | CN1191084C Medicated wine and its production process |
| 03/02/2005 | CN1191083C Eight-ingredient stomach-regulating oral liquid and preparing process thereof |
| 03/02/2005 | CN1191082C Chinese medicinal composition for treating fatty liver and its preparation method |
| 03/02/2005 | CN1191075C Composition and method for increasing weight gain and feed efficiency |
| 03/02/2005 | CN1191073C Liquid aphtha medicine and its preparing method |
| 03/01/2005 | US6861444 Treating or preventing diabetes, obesity, hyperlipidemia, digestive diseases, depression or urinary disturbances; adrenergic blocking agents |
| 03/01/2005 | US6861440 Antidiabetic agents |
| 03/01/2005 | US6861429 2,3-diaryl-pyrazolo[1,5-b]pyridazines derivatives, their preparation and their use as cyclooxygenase 2 (COX-2) inhibitors |
| 03/01/2005 | US6861425 Benzimidazole compounds as ORL1-receptor agonists |
| 03/01/2005 | US6861417 Such as 2-(4-fluorophenyl)-3-(pyridin-4-yl)pyrazine for treating cytokine mediated diseases such as psoriatic arthritis |
| 03/01/2005 | US6861412 Diphosphate salt of A 4″-substituted-9-deoxo-9A-AZA-9A-homoerythromycin derivative and its pharmaceutical composition |
| 03/01/2005 | US6861399 Cleaning compositions containing human serine protease T |
| 03/01/2005 | US6861072 Pharmaceutical composition with gastric residence and controlled release |
| 03/01/2005 | US6861069 Compression; concurrent spray drying, granulation |
| 02/24/2005 | WO2005016928A1 Imidazopyridine derivatives |
| 02/24/2005 | WO2005016897A1 Process for the preparation of 2- (quinoxalin-5-ylsulfonylamino) -benzamide compounds |
| 02/24/2005 | WO2005016896A1 2- (quinoxalin-5-ylsulfonylamino) -benzamide compounds as cck2 modulators |
| 02/24/2005 | WO2005016350A1 Ammonium salts of ornithine derivatives for treating inflammatory diseases |
| 02/24/2005 | WO2005016332A1 Compositions and methods for treating gastrointestinal conditions |
| 02/24/2005 | WO2005016225A2 Stable pharmaceutical composition of rabeprazole |
| 02/24/2005 | WO2004087195A3 Therapeutic use of modulators of notch and/or kruppel-like factors |
| 02/24/2005 | WO2004066987B1 Use of sodium channel modulators for treating gastrointestinal tract disorders |
| 02/24/2005 | US20050043545 4-(5-Membered)-heteroaryl acyl pyrrolidine derivatives as hcv inhibitors |
| 02/24/2005 | US20050043536 Sulfonamides |
| 02/24/2005 | US20050043398 such as 2-ethoxycarbonyl-7-hydroxychromone, for the care, preservation or improvement of the general state of the skin or hair |
| 02/24/2005 | US20050043394 For prophylaxis and therapy of diabetes mellitus, inflammation, cancer, necrosis, gastric ulcers, neurodegenerative diseases, neuropathic diseases, neuropathic pain and polyneuropathy; free fatty acids and/or fatty acid esters and uridine, deoxyuridine, uridine monophosphate, deoxyuridine monophosphate |
| 02/24/2005 | US20050043393 Antilipemic agents |
| 02/24/2005 | US20050043390 Viricides against herpes virus |
| 02/24/2005 | US20050043386 2-amino-2-(ethyl or methyl)-4-{5-substituted pyrrol-2-yl}butan-1-ols, phosphates and phosphonates; antiarthritic agents; psoriasis; immunosuppressants |
| 02/24/2005 | US20050043359 Kit for treatment of upper gastrointestinal tract conditions |
| 02/24/2005 | US20050043349 1-Alkyl-1-azoniabicyclo' 2.2.!octane carbamate derivatives and their use as muscarinic receptor antagonists |
| 02/24/2005 | US20050043337 Selective beta3 adrenergic agonists |
| 02/24/2005 | US20050043333 Quinazolinone derivative |
| 02/24/2005 | US20050043332 Such as 4 (cis-3-hydroxycyclopentyl)amino-5,6-dimethyl-2-phenyl-7H-pyrrolo[2,3d] pyrimidine for treatment of adenosine receptor stimulated diseases, cardiovascular disorders, and nervous system disorders |
| 02/24/2005 | US20050043310 Such as (R)-4-bromo-N-[1-(2,4-dichlorophenyl)-ethyl]-2-(quinoxaline-5-quinoxaline-sulfonylamino)-benzamide via sulfonylation; cholecystokinin receptor modulators |
| 02/24/2005 | US20050043304 Lower alkyl molecular weight amine as enzyme inhibitors for use in the treatment of tryptase enzyme inhibitors inhibitorsfor respiratory system disorders, antiinflammatory agents, inflammatory bowel disease, hyperprolific skin disorders, vascular edema and rheumatoid arthritis |
| 02/24/2005 | US20050043281 administering for treatment of metabolic bone diseases, mobilizing calcium for osteoporosis, imbalances in the immune system |
| 02/24/2005 | US20050043270 administering hyaluronic acid or a pharmaceutically acceptable salt to a human or a non-human animal to treat Crohn disease or ulcerative colitis |
| 02/24/2005 | US20050043269 Pharmaceutically active uridine esters |
| 02/24/2005 | US20050043228 Glp-1 formulations with protracted time action |
| 02/24/2005 | US20050042748 Methods for inducing differentiation of pluripotent cells |
| 02/24/2005 | US20050042738 Carbohydrate-associated proteins |
| 02/24/2005 | US20050042731 Four helical bundle cytokine family polypeptide for use in treatment, diagnosis and prevention of infection, cardiovascular, metabolic, developmental, skin, bone, inflammatory and autoimmune disorders |
| 02/24/2005 | US20050042729 Expression vector comprising nucleotide sequences conding immunoglobulin/interferon fusion for use in targeting and treatment of liver disorders |
| 02/24/2005 | US20050042317 Complex mixtures exhibiting selective inhibition of cyclooxygenase-2 |
| 02/24/2005 | US20050042308 Soft capsules containing mint oil with analgesics, antiinflammatory agents ; complex |
| 02/24/2005 | US20050042304 Novel substituted benzimidazole dosage forms and method of using same |
| 02/24/2005 | US20050042299 Use of milk serum apoproteins in the prophylaxis or treatment of microbial or viral infection |
| 02/24/2005 | US20050042237 Method for administering a spill resistant pharmaceutical system |
| 02/24/2005 | US20050042202 Gentamicin, amikacin, tobramycin, netilmicin, cephalosporin, ceftazidine, maxalactam, carbopenem, imipenem, aztreonam, ampicillin, penicillin, ureidopenicillin, augmentin, amphotericin, famvir and/or acyclovir; and Vpr protein, fragment or nucleic acid encoding; systemic inflammatory response syndrome |
| 02/24/2005 | CA2535416A1 Imidazopyridine derivatives |
| 02/24/2005 | CA2534922A1 Composition comprising a zeolite compound for treatment of diseases |
| 02/24/2005 | CA2534887A1 Process for the preparation of 2- (quinoxalin-5-ylsulfonylamino) -benzamide compounds |
| 02/23/2005 | EP1508572A1 PROTEIN INDUCING CELL DEATH OF i HELICOBACTER PYLORI /i |
| 02/23/2005 | EP1508335A1 Composition against periodontal bacteria and foods, drinks and mouth washers against periodontal bacteria containing the composition |
| 02/23/2005 | EP1508327A1 Use of chromen-4-one derivatives for the care of skin and hair |
| 02/23/2005 | EP1507780A1 Pyrazolo-pyrimidine aniline compounds useful as kinase inhibitors |
| 02/23/2005 | EP1507773A1 Macrocyclic compounds useful as pharmaceuticals |
| 02/23/2005 | EP1507767A1 4-substituted imidazole-2-thiones and imidazol-2-ones as agonists of the alpha-2b and alpha-2c adrenergic receptors |
| 02/23/2005 | EP1507765A2 Methods and compositions for treatment of central and peripheral nervous system disorders and novel compounds useful therefor |
| 02/23/2005 | EP1507760A1 Cyanoguanidine prodrugs |
| 02/23/2005 | EP1507758A2 Indole derivatives and their use as ligands for cb2 receptors |
| 02/23/2005 | EP1507756A1 Ccr9 inhibitors and methods of use thereof |
| 02/23/2005 | EP1507554A1 Lactoferrin in the treatment of malignant neoplasms and other hyperproliferative diseases |
| 02/23/2005 | EP1507553A2 Pancreas-specific proteins |
| 02/23/2005 | EP1507545A1 A terpene-based composition of substances, a method for its preparation and a method for its dispersal into the atmosphere |
| 02/23/2005 | EP1507539A1 Hormone replacement therapy using a combination of conjugated estrogens and trimegestone |
| 02/23/2005 | EP1507536A2 Compositions and their uses for alleviating pain |
| 02/23/2005 | EP1507535A1 Pyrimidine-2,4,6-trione metallo-proteinase inhibitors |
| 02/23/2005 | EP1507515A2 Free-flowing, powdery composition containing alpha-liponic acid (-derivatives) |
| 02/23/2005 | EP1317421B1 2-amino-2-alkyl-5 heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors |
| 02/23/2005 | EP1313489B1 Pharmaceutical compositions for the treatment of mucositis, stomatitis and behcet's syndrome |
| 02/23/2005 | EP1286986B1 Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain |
| 02/23/2005 | EP1274710B1 Novel heteroaryl-diazabicycloalkanes |
| 02/23/2005 | EP1140125B1 Extracts of celery seed for the prevention and treatment of inflammation and gastrointestinal irritation |
| 02/23/2005 | EP1133482B1 Il-5 inhibiting 6-azauracil derivatives |
| 02/23/2005 | EP1107962B1 Quinolin-2-one derivatives useful as anticancer agents |
| 02/23/2005 | EP1058544B1 Inhibition of tnf activity with compositions comprising heparin and soluble tnf recpetors |
| 02/23/2005 | EP1035870B1 Compositions and methods for treatment of hepatitis c virus-associated diseases |
| 02/23/2005 | CN1585778A Modified anti-TNF alpha antibody |
| 02/23/2005 | CN1585772A Chemokine receptor antagonists and methods of use thereof |
| 02/23/2005 | CN1585771A Polycyclic guanine derivative phosphodiesterase V inhibitors |
| 02/23/2005 | CN1585770A Reverse-turn mimetics and method relating thereto |
| 02/23/2005 | CN1585769A A2b adenosine receptor antagonists |
| 02/23/2005 | CN1585763A Piperidine derivatives and their use as modulators of chemokine receptor activity especially CCR5 |
| 02/23/2005 | CN1585757A Oligopeptides and compositions containing them as cathepsin S inhibitors |
| 02/23/2005 | CN1585755A Benzamide and heteroarylamide as P2X7 receptor antagonists |